Suzhou MyLand Pharm&Nutrition Inc.

Suzhou MyLand Pharm&Nutrition Inc.

You are here: HomeProductsAgomelatine

Contact us

  • Company Name: Suzhou MyLand Pharm&Nutrition Inc.
  • Street: No.100,Jinmen Rd. Suzhou
  • City: Suzhou
  • Province/state: Jiangsu
  • Country/region: China
  • Contact Person: Ms.Brenda Zhou
  • Department: Sales
  • Tel: 86-512-66702819
  • Fax: --
  • Email:
  • Chat with supplier using
    frankfan169@hotmail.com

Agomelatine

  • CAS No:138112-76-2 N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide
    Molecular Structure

    Detailed Description

    Product Name:Agomelatine
    CAS # 138112-76-2
    Appearance: white powder
    Purity: 99.5%
    Package: 1kg per bag


    Agomelatine (brand names Valdoxan, Melitor, Thymanax) is an atypical antidepressant developed by the pharmaceutical company Servier. It is marketed for the treatment of major depressive disorder, primarily for its relatively favorable side effect profile: it avoids the weight gain, sexual dysfunction, and severe withdrawal associated with the most commonly used classes of antidepressants (SSRIs, SNRIs, tricyclics), while providing similar therapeutic benefit.
    Due to its distinctive mechanism of action, agomelatine is also studied for its effects on sleep regulation. Studies report various improvements in general quality of sleep metrics, as well as specific therapeutic benefits in circadian rhythm disorders.
    Agomelatine is indicated for the treatment of major depressive episodes in adults. Ten placebo controlled trials have been performed to investigate the short term efficacy of agomelatine in major depressive disorder. At the end of treatment, significant efficacy was demonstrated in six of the ten short-term double-blind placebo-controlled studies. Two were considered "failed" trials, as comparators of established efficacy failed to differentiate from placebo. Efficacy was also observed in more severely depressed patients in all positive placebo-controlled studies.The maintenance of antidepressant efficacy was demonstrated in a relapse prevention study. A large meta-analysis of 20 trials with 7460 participants found agomelatine to be as effective as standard antidepressants.
  • Agomelatine
  • Agomelatine